Search research articles
Contact Us
Filters
Showing results (11-20 of 15) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 15 results.
Molecular Reproduction and Development
|
March 26, 1999
Timing of DNA integration, transgenic mosaicism, and pronuclear microinjection
A W Chan, G Kukolj, A M Skalka, et al.
Biochemistry
|
September 6, 1994
Secondary structure and interaction of phage D108 Ner repressor with a 61-base-pair operator: evidence for altered protein and DNA structures in the complex
J M Benevides, G Kukolj, C Autexier, et al.
Antimicrobial Agents and Chemotherapy
|
July 22, 2015
Baseline Polymorphisms and Emergence of Drug Resistance in the NS3/4A Protease of Hepatitis C Virus Genotype 1 following Treatment with Faldaprevir and Pegylated Interferon Alpha 2a/Ribavirin in Phase 2 and Phase 3 Studies
K L Berger, J Scherer, M Ranga, et al.
The Journal of Biological Chemistry
|
June 22, 1999
Solution structure of substrate-based ligands when bound to hepatitis C virus NS3 protease domain
S R LaPlante, D R Cameron, N Aubry, et al.
Bioorganic & Medicinal Chemistry Letters
|
October 31, 2000
NMR line-broadening and transferred NOESY as a medicinal chemistry tool for studying inhibitors of the hepatitis C virus NS3 protease domain
S R LaPlante, N Aubry, P R Bonneau, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 15) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 15 results.
Molecular Reproduction and Development
|
March 26, 1999
Timing of DNA integration, transgenic mosaicism, and pronuclear microinjection
A W Chan, G Kukolj, A M Skalka, et al.
Biochemistry
|
September 6, 1994
Secondary structure and interaction of phage D108 Ner repressor with a 61-base-pair operator: evidence for altered protein and DNA structures in the complex
J M Benevides, G Kukolj, C Autexier, et al.
Antimicrobial Agents and Chemotherapy
|
July 22, 2015
Baseline Polymorphisms and Emergence of Drug Resistance in the NS3/4A Protease of Hepatitis C Virus Genotype 1 following Treatment with Faldaprevir and Pegylated Interferon Alpha 2a/Ribavirin in Phase 2 and Phase 3 Studies
K L Berger, J Scherer, M Ranga, et al.
The Journal of Biological Chemistry
|
June 22, 1999
Solution structure of substrate-based ligands when bound to hepatitis C virus NS3 protease domain
S R LaPlante, D R Cameron, N Aubry, et al.
Bioorganic & Medicinal Chemistry Letters
|
October 31, 2000
NMR line-broadening and transferred NOESY as a medicinal chemistry tool for studying inhibitors of the hepatitis C virus NS3 protease domain
S R LaPlante, N Aubry, P R Bonneau, et al.
Page
of 2